ICP-MS for metal-complexed peptides and elemental impurities

Two compounds in this index are metal complexes by design: GHK-Cu, a copper(II) complex of glycyl-histidyl-lysine, and thymulin, whose activity is zinc-dependent. For both, a reverse-phase purity figure describes the peptide and says nothing whatsoever about the metal — and worse, the method actively destroys the thing being measured.

Why the chromatography fails

The index reference method uses 0.1 % trifluoroacetic acid, giving a mobile-phase pH near 2. At that pH the histidine imidazole and the peptide amide nitrogens that coordinate copper are protonated, the complex dissociates, and what reaches the detector is apo-GHK. The chromatogram of authentic GHK-Cu is a chromatogram of the free peptide with a copper-shaped absence.

The practical consequence: a GHK-Cu lot containing no copper at all and a GHK-Cu lot fully complexed will produce very similar reverse-phase chromatograms and very similar purity figures. The purity number cannot distinguish the product from its raw material.

What to measure instead

1. Peptide purity by RP-HPLC, understood explicitly as apo-peptide purity.
2. Copper (or zinc) content by ICP-MS after acid digestion, or by ICP-OES, or by a colourimetric assay. Reported as %w/w and compared against the stoichiometric prediction.
3. Complexation stoichiometry from the ratio of the two, which is the number that says whether the material is what it claims to be.

GHK-Cu: peptide GHK = 340.38 Da, Cu = 63.55 Da
Stoichiometric 1:1 complex, M = 401.91 Da (as the neutral complex)

  predicted Cu content = 63.55 / 401.91 × 100 = 15.81 %w/w

Measured Cu (ICP-MS):  14.9 %w/w
  → 0.94 × stoichiometric.  Consistent with near-complete complexation.

Measured Cu:  4.1 %w/w
  → 0.26 × stoichiometric.  Roughly a quarter complexed; three quarters
    of the material is apo-peptide sold as the complex.
    RP-HPLC purity on both samples: indistinguishable.

Elemental impurities more generally

ICP-MS also quantifies the elemental impurities in ICH Q3D classes 1 to 3 — cadmium, lead, arsenic, mercury, cobalt, vanadium, nickel and the platinum-group metals. For peptides made by solid-phase synthesis the relevant risks are palladium and copper from any catalysed step, and nickel and chromium from stainless-steel process equipment. No report in this index carries an elemental-impurity profile.